News
AstraZeneca to showcase innovation in infectious disease protection at ESCMID Global 2025: Cambridge, UK Thursday, April 10, 2025, 15:00 Hrs [IST] AstraZeneca will share new data ...
4, 2025 — Low vaccination rates for influenza viruses ... pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms.
Sanofi has a plan to make it a ‘backbone’ of a combination respiratory vaccine that could include other components such as human metapneumovirus and parainfluenza virus. The drugmaker will ...
Discover the latest drugs and treatment options in the Influenza Pipeline. Dive into DelveInsight's comprehensive report ...
Healthbeat on MSN2d
Reports of ‘Disease X’? Here’s how to think clearly when you hear about an outbreakIn a world where information travels far faster than infections, it is more important than ever to think critically about ...
At ESCMID Global 2025 in Vienna, AstraZeneca will present a comprehensive data package from its Vaccines & Immune Therapies portfolio, featur ...
German turkey breeder company shares its experience-based evaluation on four methods of avian metapneumovirus vaccine ...
Turkey growers are suffering losses from a disease that first appeared in the U.S. a year ago. Iowa Turkey Federation executive director Gretta Irwin says poultry health is a concern for growers.
A second child died from measles-related causes in Texas where an outbreak has infected at least 505. Until this year, the ...
Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...
Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results